Log in to access this content.

Amid Eli Lilly’s expanding legal fight with compounders and online peptide sellers marketing its experimental weight-loss drug retatrutide, FDA has sent another tranche of warning letters to five ...

Just days after Solicitor General D. John Sauer conceded the Department of Justice could no longer defend FDA’s in-house civil penalties against tobacco retailers simply by invoking public health or ...

FDA is warning consumers taking compounded versions of GLP-1 medications that all vials should be discarded after 28 days, regardless of whether all doses have been used, saying holding onto vials for ...

As HHS and the Department of Justice continue to fight multiple court battles over an array of Trump administration health care policies, major cases over the Trump administration’s overhaul of CDC’s ...

While CMS’ most recent exchange rule requires insurers to report their actual plan year 2025 cost-sharing reduction (CSR) expenditures in their 2027 rate filings, the agency is granting enforcement ...

The Trump administration's revamp of the 1115 waiver budget neutrality process will likely affect the 15 states with demonstrations set to expire in 2026, according to a Manatt analysis released this ...

Democrats on the Senate Finance Committee are interested in establishing a subscription model to boost access to medicines like GLP-1s, one of many affordability policies lawmakers are considering ...

Multiple academic medical centers are positioning themselves as candidates for FDA’s new pilot that aims to accelerate clinical research by asking research institutions to play a larger role in ...

The health insurance industry is highlighting a new Health Affairs analysis that finds the No Surprises Act’s independent dispute resolution process resulted in $22.4 billion in costs from 2022 to ...

As key Senate Democrats seek input on ways to design a public insurance option to cut health care costs, some prominent health care experts suggest a better way to improve federal health care ...

The American Medical Association (AMA) is hosting a series on the ethical use of artificial intelligence in medicine, which will count towards continuing medical education credits, to help physicians ...